Invention Grant
- Patent Title: Fused pyrimidines as inhibitors of P97 complex
-
Application No.: US15264007Application Date: 2016-09-13
-
Publication No.: US10010554B2Publication Date: 2018-07-03
- Inventor: Han-Jie Zhou , Francesco Parlati , David Wustrow
- Applicant: Cleave Biosciences, Inc.
- Applicant Address: US CA Burlingame
- Assignee: Cleave Biosciences, Inc.
- Current Assignee: Cleave Biosciences, Inc.
- Current Assignee Address: US CA Burlingame
- Agency: Schwegman Lundberg & Woessner, P.A.
- Main IPC: C07D403/04
- IPC: C07D403/04 ; C07D471/04 ; C07D495/04 ; C07D491/048 ; C07D491/052 ; A61K31/517 ; A61K31/519

Abstract:
Fused pyrimidine compounds having a saturated, unsaturated or aromatic A ring fused to a pyrimidine ring and having a complex substituents at the 2 position and a substituted amine at the 4 position of the pyrimidine ring as well as optional aliphatic, functional and/or aromatic components substituted at other positions of the pyrimidine ring and A ring are disclosed. These compounds are inhibitors of the AAA proteasome complex containing p97 and are effective medicinal agents for treatment of diseases associated with p97 bioactivity such as cancer.
Public/Granted literature
- US20170258795A1 FUSED PYRIMIDINES AS INHIBITORS OF P97 COMPLEX Public/Granted day:2017-09-14
Information query